Capital Fund Management (CFM)
AZN icon

Capital Fund Management (CFM)’s AstraZeneca AZN Stock Holding History

Capital Fund Management (CFM)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-36,900
Closed -$7.28M – 2078
2026
Q1 		$7.28M Buy
36,900
+21,700
+143% +$4.18M 0.03% 710
2025
Q4 		$2.79M Buy
15,200
+1,950
+15% +$342K 0.01% 1530
2025
Q3 		$2.03M Buy
+13,250
New +$2.01M 0.01% 1783
2025
Q2 		– Sell
-16,400
Closed -$2.41M – 2333
2025
Q1 		$2.41M Sell
16,400
-6,450
-28% -$933K 0.01% 1329
2024
Q4 		$2.99M Buy
22,850
+10,350
+83% +$1.45M 0.01% 1330
2024
Q3 		$1.95M Buy
+12,500
New +$2.02M 0.01% 1446
2023
Q4 		– Sell
-10,350
Closed -$1.4M – 2098
2023
Q3 		$1.4M Buy
10,350
+1,700
+20% +$232K ﹤0.01% 1514
2023
Q2 		$1.24M Sell
8,650
-9,000
-51% -$1.32M 0.01% 1341
2023
Q1 		$2.45M Sell
17,650
-4,200
-19% -$565K 0.01% 997
2022
Q4 		$2.96M Sell
21,850
-27,300
-56% -$3.42M 0.02% 807
2022
Q3 		$5.39M Buy
49,150
+16,900
+52% +$2.14M 0.04% 523
2022
Q2 		$4.26M Buy
32,250
+24,800
+333% +$3.25M 0.04% 556
2022
Q1 		$988K Buy
+7,450
New +$893K 0.01% 1156
2020
Q2 		– Sell
-2,700
Closed -$241K – 1041
2020
Q1 		$241K Sell
2,700
-1,000
-27% -$94.1K ﹤0.01% 1323
2019
Q4 		$369K Buy
+3,700
New +$348K ﹤0.01% 1521
2015
Q1 		– Sell
-14,100
Closed -$992K – 1426
2014
Q4 		$992K Sell
14,100
-2,800
-17% -$200K 0.01% 888
2014
Q3 		$1.21M Sell
16,900
-39,200
-70% -$2.87M 0.01% 859
2014
Q2 		$4.17M Buy
56,100
+12,300
+28% +$889K 0.04% 476
2014
Q1 		$2.84M Buy
43,800
+12,800
+41% +$827K 0.03% 548
2013
Q4 		$1.84M Buy
31,000
+12,700
+69% +$690K 0.02% 731
2013
Q3 		$950K Buy
+18,300
New +$919K 0.01% 894

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Fund Management (CFM)'s AZN Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 51,161 shares — an estimated $10.1M sold.

Capital Fund Management (CFM) first reported a position in AZN in Q2 2013 and held it in 22 quarters. The position peaked at $40.3M in Q4 2023. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 51,161 AstraZeneca shares in Q2 2026, an estimated $10.1M.
  • Capital Fund Management (CFM) first reported a position in AstraZeneca in Q2 2013 and held it in 22 quarters.
  • Capital Fund Management (CFM)'s AstraZeneca position peaked at $40.3M in Q4 2023.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.